Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Silke Salavati

Silke Salavati

The Roslin Institute University of Edinburgh UK

Alex Maughan

Alex Maughan

Foundation Doctor at Papworth Hospital UK

Fred Tenover

Fred Tenover

Scientific Affairs Cepheid USA

Teresa Coque

Teresa Coque

Hospital Ramon Y Cajal Spain

Martin Duerden

Martin Duerden

Bangor University UK

David Denning

David Denning

University of Manchester UK

Astrid Pentz-Murr

Astrid Pentz-Murr

GARDP Switzerland

Kartik Cherabuddi

Kartik Cherabuddi

University of Florida USA

Antibiotics 2022

Sessions / Tracks

After a successful conference of Antibiotics 2021, we are currently bringing forth “9­th World Congress and Exhibition on Antibiotics and Antibiotic Resistance” (Antibiotics 2022) slated on March 07-08, 2022 at Barcelona, Spain. Antibiotics 2022 aims to gather the most elegant societies and industries along with the renowned and honorable persons from top universities across the globe.

Antibiotics 2022 covers various aspects of Antibiotics, The Emergence of Antimicrobial resistance, Different Types of Antibiotics, Applications of Antibiotics, Antibiotic Resistance: Opportunities and Challenges, Antibiotics for Various Diseases and Infections, Antibiotic Prophylaxis, Antibiotics: In Pregnancy and Lactation, Antibiotics in Different Industries, Modern Antibiotics: Emerging trends, Barriers and Opportunities, Drug Discovery and Novel Delivery Technologies, Antibiotics for Emerging and Re-emerging Diseases, Micro Organisms in Recent Drug Discovery, Clinical Trials of Antibiotics, Antibiotics and Mechanism, Antibiotic Regulatory Affairs and Antibiotics Market Analysis and Business Opportunities.

Track 1: Antibiotics

Antibiotics are a type of antimicrobials that are used in treatment and prevention of bacterial infections. They may kill or inhibit the growth of bacteria. Many antibiotics are also effective against protozoans and fungi; some are toxic to humans and animals also, even when given in therapeutic dosage. Antibiotics are not effective against viruses such as common cold or influenza, and may be harmful when taken inappropriately. Physicians must ensure the patient has a bacterial infection before prescribing antibiotics.

Relevant Conferences:

7th World Congress on Clinical Microbiology, February 27-28, 2022 Amsterdam, Netherlands; Global Pharmaceutical Microbiology Conference, June 19-20, 2022 London, UK; Annual Conference on Antimicrobials and Drug Resistance, August 24-25, 2022 Toronto, Canada; 2nd International Conference on Infectious Diseases & Diagnostic Microbiology, Sep 11-13, 2022 Dallas, USA; 4th World Congress and Expo on Applied Microbiology, Sep 18-20, 2022 Atlanta, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2022 Atlanta, USA; 2nd International Symposium, Alternatives to Antibiotics, Challenges and Solutions in Animal Production, December 13-15, 2016 Paris, France; Microbiome in Health and Disease, February 5-9, 2022 Colorado, USA; Innovative Strategies in the Research and Development of Antimicrobial Peptides to Increase Therapeutic Potential, February 25-26, 2022 Ventura, CA; How Animals and Plants Use Antimicrobial Peptides, How They Work, and How to Design Interesting New Molecules, February 26 - March 3, 2022 Ventura, CA; 19th International Conference on Antimicrobials, March 9-10, 2022 Miami, USA; BSAC Spring Conference: The Global Challenge of Multi-drug Resistant Gram Negative Bacterial Infections, 14th March 2022, Queen Elizabeth II Conference Centre, London; Solutions for Drug-Resistant Infections Conference, April 3-5, 2022 Brisbane, Australia; ASM Conference on Innovative Microbial Ecology for Mitigation of Antibiotic Resistance and Bacterial Diseases, March 22–25, 2022 Crystal City, VA; 27th European Congress of Clinical Microbiology and Infectious Diseases, April 22- 25 2022 Vienna, Austria; 20th Annual MAD-ID Meeting – THE Antimicrobial Stewardship Meeting™, May 10-13, 2022 Orlando, USA

Related Societies:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), Center for a Livable Future (CLF), U.S. Food and Drug Administration (FDA), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsTransatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP)

Track 2: The Emergence of Antimicrobial Resistance

Antibiotic resistance invoke especially to the resistance to antibiotics that occurs in common bacteria that cause infection. The easy approach and capability of Antibiotics led to overuse in live-stock raising promotes bacteria to flourish resistance. This led to comprehensive problems with antibiotic resistance. World Health Organization (WHO) classified antimicrobial resistance as a serious hazard and no longer a indicator for the future. Antibiotic resistance is now among every part of the world and its stirring everyone irrespective to the age. When infections become resistant to first-line drugs, more costly therapies must be used. A longer duration of illness and treatment, often in hospitals, increases health care costs as well as the financial burden on families and societies. To help prevent the development of current and future bacterial resistance, it is essential to prescribe antibiotics according to the principles of antimicrobial stewardship, such as specify antibiotics only when they are needed.

Relevant Conferences:

Global Pharmaceutical Microbiology Conference, June 19-20, 2022 London, UK; Annual Conference on Antimicrobials and Drug Resistance, August 24-25, 2022 Toronto, Canada; 2nd International Conference on Infectious Diseases & Diagnostic Microbiology, Sep 11-13, 2022 Dallas, USA; 4th World Congress and Expo on Applied Microbiology, Sep 18-20, 2022 Atlanta, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2022 Atlanta, USA; BSAC Spring Conference: The Global Challenge of Multi-drug Resistant Gram Negative Bacterial Infections, 14th March 2022, Queen Elizabeth II Conference Centre, London; Solutions for Drug-Resistant Infections Conference, April 3-5, 2022 Brisbane, Australia; ASM Conference on Innovative Microbial Ecology for Mitigation of Antibiotic Resistance and Bacterial Diseases, March 22–25, 2022 Crystal City, VA; 27th European Congress of Clinical Microbiology and Infectious Diseases, April 22- 25 2022 Vienna, Austria; 20th Annual MAD-ID Meeting – THE Antimicrobial Stewardship Meeting™, May 10-13, 2022 Orlando, USA; ASM Microbe 2022, June 1-5, 2022 New Orleans, USA; 2nd International Caparica Conference in Antibiotic Resistance, June 12-15, 2022 Lisbon, Portugal; World Anti-Microbial Resistance Congress USA 2022, September 14-15, 2022 Washington, USA; 11th International Symposium on the Biology of Acinetobacter, September 20-22, 2022 Seville, Spain; Host Directed Therapeutic Strategies to Combat Infection and Reduce Emergence of Drug Resistance Conference, Sep 25- 28 2022, Arizona USA; 19th International Conference on Antibiotics, Bioactive Compounds and Medicine, October 10-11, 2022 New York, USA

Related Societies:

British Pharmacological Society (BPS), American Society for Microbiology (ASM), Infectious Diseases Society of America (IDSA), The American Society of Health-System Pharmacists, The Society of Infectious Diseases Pharmacists, Animal Welfare Approved (AWA), American Academy of PediatricsAmerican Medical AssociationCompassion in World Farming (CIWF), Center for Science in the Public Interest (CSPI), Keep Antibiotics Working (KAW), Institute for Agriculture and Trade Policy (IATP), Healthy Food Action

Track 3: Antibiotic Resistance: Opportunities and Challenges

Certain bacterial infections now oppose all antibiotics. The resistance problem may be reversible, but only if society begins to acknowledge how the drugs affect "good" bacteria as well as "bad". Historically, most antibacterials were used in hospitals, where they were integrated into surgical clothes and soaps to limit the spread of infection. More recently, however, those substances (including triclosan, triclocarbon and such quaternary ammonium compounds as benzalkonium chloride) have been mixed into lotions, dish-washing detergents and soaps meant for general consumers. They have also been impregnated into such items as cutting boards, toys, high chairs and mattress pads.

Relevant Conferences:

Annual Conference on Antimicrobials and Drug Resistance, August 24-25, 2022 Toronto, Canada; 2nd International Conference on Infectious Diseases & Diagnostic Microbiology, Sep 11-13, 2022 Dallas, USA; 4th World Congress and Expo on Applied Microbiology, Sep 18-20, 2022 Atlanta, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2022 Atlanta, USA; ASM Microbe 2022, June 1-5, 2022 New Orleans, USA; 2nd International Caparica Conference in Antibiotic Resistance, June 12-15, 2022 Lisbon, Portugal; World Anti-Microbial Resistance Congress USA 2022, September 14-15, 2022 Washington, USA; 11th International Symposium on the Biology of Acinetobacter, September 20-22, 2022 Seville, Spain; Host Directed Therapeutic Strategies to Combat Infection and Reduce Emergence of Drug Resistance Conference, Sep 25- 28 2022, Arizona USA; 19th International Conference on AntibioticsBioactive Compounds and Medicine, October 10-11, 2022 New York, USA

Related Societies:

Antibiotic Research UK (ANTRUK), Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), Center for a Livable Future (CLF), U.S. Food and Drug Administration (FDA), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsTransatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), British Pharmacological Society (BPS)

Track 4: Different Types of Antibiotics

Antibiotics are also noted as antibacterials, are types of medications that destroy or slow down the growth of bacteria. Alexander Fleming discovered first penicillin, the first chemical compound with antibiotic properties. Some of the common antibiotics are Aminoglycosides, Cephalosporins, Carbapenems, Macrolides, Penicillin, Quinolones, Sulfonamides and, Tetracyclines etc. General fundamentals of antibiotic prescribing are use: First-line antibiotics first, Reserve broad spectrum antibiotics for marked circumstances only, prescribe antibiotics for bacterial infections if Symptoms are significant or severe.

Relevant Conferences:

2nd International Conference on Infectious Diseases & Diagnostic Microbiology, Sep 11-13, 2022 Dallas, USA; 4th World Congress and Expo on Applied Microbiology, Sep 18-20, 2022 Atlanta, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2022 Atlanta, USA; 2nd International Symposium, Alternatives to Antibiotics, Challenges and Solutions in Animal Production, December 13-15, 2016 Paris, France; Microbiome in Health and Disease, February 5-9, 2022 Colorado, USA; Innovative Strategies in the Research and Development of Antimicrobial Peptides to Increase Therapeutic Potential, February 25-26, 2022 Ventura, CA; How Animals and Plants Use Antimicrobial Peptides, How They Work, and How to Design Interesting New Molecules, February 26 - March 3, 2022 Ventura, CA; 19th International Conference on Antimicrobials, March 9-10, 2022 Miami, USA; BSAC Spring Conference: The Global Challenge of Multi-drug Resistant Gram Negative Bacterial Infections, 14th March 2022, Queen Elizabeth II Conference Centre, London; Solutions for Drug-Resistant Infections Conference, April 3-5, 2022 Brisbane, Australia

Related Societies:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), Center for a Livable Future (CLF), U.S. Food and Drug Administration (FDA), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsTransatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), British Pharmacological Society (BPS), American Society for Microbiology (ASM), Infectious Diseases Society of America (IDSA)

Track 5: Applications of Antibiotics

Choice of relevant antibiotics is presently based on individual patient need. Preservation of bacterial sensitivity needs perceptive of how antibiotics select resistance. ‘Ten commandments’ which might be considered carefully when a preference has to be made for antibiotic prescribing. The compelling importance of the fact that all healthcare personnel should take ownership of the need to specify accordingly and to practice effective infection control. A realization that antibiotics may not be competent for the tasks required of them and eventually, with widespread resistance, may be incapable of the task they do today.

Relevant Conferences:

7th World Congress on Clinical Microbiology, February 27-28, 2022 Amsterdam, Netherlands; Global Pharmaceutical Microbiology Conference, June 19-20, 2022 London, UK; Annual Conference on Antimicrobials and Drug Resistance, August 24-25, 2022 Toronto, Canada; 2nd International Conference on Infectious Diseases & Diagnostic Microbiology, Sep 11-13, 2022 Dallas, USA; 4th World Congress and Expo on Applied Microbiology, Sep 18-20, 2022 Atlanta, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2022 Atlanta, USA; 2nd International Symposium, Alternatives to Antibiotics, Challenges and Solutions in Animal Production, December 13-15, 2016 Paris, France; Microbiome in Health and Disease, February 5-9, 2022 Colorado, USA; Innovative Strategies in the Research and Development of Antimicrobial Peptides to Increase Therapeutic Potential, February 25-26, 2022 Ventura, CA; How Animals and Plants Use Antimicrobial Peptides, How They Work, and How to Design Interesting New Molecules, February 26 - March 3, 2022 Ventura, CA; 19th International Conference on Antimicrobials, March 9-10, 2022 Miami, USA; BSAC Spring Conference: The Global Challenge of Multi-drug Resistant Gram Negative Bacterial Infections, 14th March 2022, Queen Elizabeth II Conference Centre, London; Solutions for Drug-Resistant Infections Conference, April 3-5, 2022 Brisbane, Australia; ASM Conference on Innovative Microbial Ecology for Mitigation of Antibiotic Resistance and Bacterial Diseases, March 22–25, 2022 Crystal City, VA; 27th European Congress of Clinical Microbiology and Infectious Diseases, April 22- 25 2022 Vienna, Austria; 20th Annual MAD-ID Meeting – THE Antimicrobial Stewardship Meeting™, May 10-13, 2022 Orlando, USA

Related Societies:

 Centers for Disease Control and Prevention (CDC), Center for a Livable Future (CLF), U.S. Food and Drug Administration (FDA), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsTransatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), British Pharmacological Society (BPS), American Society for Microbiology (ASM), Infectious Diseases Society of America (IDSA), The American Society of Health-System Pharmacists

Track 6: Antibiotics for Various Diseases and Infections

Antibiotics are amidst the most regularly recommended medications in modern medicine. Antibiotics are useless against viral infections. When you take antibiotics, follow the guidelines carefully. It is important to finish your medicine even if you feel improved. If you stop treatment too soon, some bacteria may survive and re-infect you. Do not save antibiotics for later or use someone else's prescription.

Relevant Conferences:

Global Pharmaceutical Microbiology Conference, June 19-20, 2022 London, UK; Annual Conference on Antimicrobials and Drug Resistance, August 24-25, 2022 Toronto, Canada; 2nd International Conference on Infectious Diseases & Diagnostic Microbiology, Sep 11-13, 2022 Dallas, USA; 4th World Congress and Expo on Applied Microbiology, Sep 18-20, 2022 Atlanta, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2022 Atlanta, USA; BSAC Spring Conference: The Global Challenge of Multi-drug Resistant Gram Negative Bacterial Infections, 14th March 2022, Queen Elizabeth II Conference Centre, London; Solutions for Drug-Resistant Infections Conference, April 3-5, 2022 Brisbane, Australia; ASM Conference on Innovative Microbial Ecology for Mitigation of Antibiotic Resistance and Bacterial Diseases, March 22–25, 2022 Crystal City, VA; 27th European Congress of Clinical Microbiology and Infectious Diseases, April 22- 25 2022 Vienna, Austria; 20th Annual MAD-ID Meeting – THE Antimicrobial Stewardship Meeting™, May 10-13, 2022 Orlando, USA; ASM Microbe 2022, June 1-5, 2022 New Orleans, USA; 2nd International Caparica Conference in Antibiotic Resistance, June 12-15, 2022 Lisbon, Portugal; World Anti-Microbial Resistance Congress USA 2022, September 14-15, 2022 Washington, USA; 11th International Symposium on the Biology of Acinetobacter, September 20-22, 2022 Seville, Spain; Host Directed Therapeutic Strategies to Combat Infection and Reduce Emergence of Drug Resistance Conference, Sep 25- 28 2022, Arizona USA; 19th International Conference on Antibiotics, Bioactive Compounds and Medicine, October 10-11, 2022 New York, USA

Related Societies:

 Center for a Livable Future (CLF), U.S. Food and Drug Administration (FDA), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsTransatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), British Pharmacological Society (BPS), American Society for Microbiology (ASM), Infectious Diseases Society of America (IDSA), The American Society of Health-System Pharmacists, The Society of Infectious Diseases Pharmacists

Track 7: Antibiotic Prophylaxis

Antimicrobial prophylaxis is generally used by clinicians for the prevention of numerous infectious diseases. Optimal antimicrobial agents for prophylaxis should be nontoxic, inexpensive, bactericidal and active against the typical pathogens that can motive surgical site infection postoperatively. To maximize its effectiveness, intravenous perioperative prophylaxis should be carried out within 30 to 60 minutes before the surgical incision. Antimicrobial prophylaxis should be of short time to downturn toxicity and antimicrobial resistance and to reduce cost.

Relevant Conferences:

Annual Conference on Antimicrobials and Drug Resistance, August 24-25, 2022 Toronto, Canada; 2nd International Conference on Infectious Diseases & Diagnostic Microbiology, Sep 11-13, 2022 Dallas, USA; 4th World Congress and Expo on Applied Microbiology, Sep 18-20, 2022 Atlanta, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2022 Atlanta, USA; ASM Microbe 2022, June 1-5, 2022 New Orleans, USA; 2nd International Caparica Conference in Antibiotic Resistance, June 12-15, 2022 Lisbon, Portugal; World Anti-Microbial Resistance Congress USA 2022, September 14-15, 2022 Washington, USA; 11th International Symposium on the Biology of Acinetobacter, September 20-22, 2022 Seville, Spain; Host Directed Therapeutic Strategies to Combat Infection and Reduce Emergence of Drug Resistance Conference, Sep 25- 28 2022, Arizona USA; 19th International Conference on AntibioticsBioactive Compounds and Medicine, October 10-11, 2022 New York, USA

Related Societies:

U.S. Food and Drug Administration (FDA), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsTransatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), British Pharmacological Society (BPS), American Society for Microbiology (ASM), Infectious Diseases Society of America (IDSA), The American Society of Health-System Pharmacists, The Society of Infectious Diseases Pharmacists, Animal Welfare Approved (AWA), American Academy of Pediatrics

Track 8: Antibiotics: In Pregnancy and Lactation

Antibiotics are frequently recommended during pregnancy. The specific medication must be chosen carefully, however. Some antibiotics are prescribed to take during pregnancy, while others are not. Safety depends on various factors, including the type of antibiotic, when in pregnancy you take the antibiotic, how much you take and for how long. Antibiotics normally advised safe during pregnancy: Ampicillin, Amoxicillin, Clindamycin, Erythromycin, Penicillin, Nitrofurantoin. Despite there's no direct clue that these antibiotics cause birth defects, additional research is needed. In the interim, use of these medications is still assured in some cases.

Relevant Conferences:

Global Pharmaceutical Microbiology Conference, June 19-20, 2022 London, UK; Annual Conference on Antimicrobials and Drug Resistance, August 24-25, 2022 Toronto, Canada; 2nd International Conference on Infectious Diseases & Diagnostic Microbiology, Sep 11-13, 2022 Dallas, USA; 4th World Congress and Expo on Applied Microbiology, Sep 18-20, 2022 Atlanta, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2022 Atlanta, USA; BSAC Spring Conference: The Global Challenge of Multi-drug Resistant Gram Negative Bacterial Infections, 14th March 2022, Queen Elizabeth II Conference Centre, London; Solutions for Drug-Resistant Infections Conference, April 3-5, 2022 Brisbane, Australia; ASM Conference on Innovative Microbial Ecology for Mitigation of Antibiotic Resistance and Bacterial Diseases, March 22–25, 2022 Crystal City, VA; 27th European Congress of Clinical Microbiology and Infectious Diseases, April 22- 25 2022 Vienna, Austria; 20th Annual MAD-ID Meeting – THE Antimicrobial Stewardship Meeting™, May 10-13, 2022 Orlando, USA; ASM Microbe 2022, June 1-5, 2022 New Orleans, USA; 2nd International Caparica Conference in Antibiotic Resistance, June 12-15, 2022 Lisbon, Portugal; World Anti-Microbial Resistance Congress USA 2022, September 14-15, 2022 Washington, USA; 11th International Symposium on the Biology of Acinetobacter, September 20-22, 2022 Seville, Spain; Host Directed Therapeutic Strategies to Combat Infection and Reduce Emergence of Drug Resistance Conference, Sep 25- 28 2022, Arizona USA; 19th International Conference on Antibiotics, Bioactive Compounds and Medicine, October 10-11, 2022 New York, USA

Related Societies:

 BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsTransatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), British Pharmacological Society (BPS), American Society for Microbiology (ASM), Infectious Diseases Society of America (IDSA), The American Society of Health-System Pharmacists, The Society of Infectious Diseases Pharmacists, Animal Welfare Approved (AWA), American Academy of PediatricsAmerican Medical AssociationCompassion in World Farming (CIWF)

Track 9: Antibiotics in Different Industries

Antibiotics must be used accordingly in humans and animals because both uses share to the emergence, persistence, and escalation of resistant bacteria. Resistant bacteria in food-producing animals are of particular concern. Food animals play as a source of resistant pathogens and resistance mechanisms that can directly or indirectly result in antibiotic resistant infections in humans. Resistant bacteria may be transmitted to humans through the foods we eat. Some bacteria have turned resistant to more than one sort of antibiotic, which makes it more difficult to treat the infections they cause. Sustaining the efficiency of antibiotic drugs is vital to insulating human and animal health.

Relevant Conferences:

7th World Congress on Clinical Microbiology, February 27-28, 2022 Amsterdam, Netherlands; Global Pharmaceutical Microbiology Conference, June 19-20, 2022 London, UK; Annual Conference on Antimicrobials and Drug Resistance, August 24-25, 2022 Toronto, Canada; 2nd International Conference on Infectious Diseases & Diagnostic Microbiology, Sep 11-13, 2022 Dallas, USA; 4th World Congress and Expo on Applied Microbiology, Sep 18-20, 2022 Atlanta, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2022 Atlanta, USA; 2nd International Symposium, Alternatives to Antibiotics, Challenges and Solutions in Animal Production, December 13-15, 2016 Paris, France; Microbiome in Health and Disease, February 5-9, 2022 Colorado, USA; Innovative Strategies in the Research and Development of Antimicrobial Peptides to Increase Therapeutic Potential, February 25-26, 2022 Ventura, CA; How Animals and Plants Use Antimicrobial Peptides, How They Work, and How to Design Interesting New Molecules, February 26 - March 3, 2022 Ventura, CA; 19th International Conference on Antimicrobials, March 9-10, 2022 Miami, USA; BSAC Spring Conference: The Global Challenge of Multi-drug Resistant Gram Negative Bacterial Infections, 14th March 2022, Queen Elizabeth II Conference Centre, London; Solutions for Drug-Resistant Infections Conference, April 3-5, 2022 Brisbane, Australia; ASM Conference on Innovative Microbial Ecology for Mitigation of Antibiotic Resistance and Bacterial Diseases, March 22–25, 2022 Crystal City, VA; 27th European Congress of Clinical Microbiology and Infectious Diseases, April 22- 25 2022 Vienna, Austria; 20th Annual MAD-ID Meeting – THE Antimicrobial Stewardship Meeting™, May 10-13, 2022 Orlando, USA

Related Societies:

ReAct – Action on AntibioticsTransatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), British Pharmacological Society (BPS), American Society for Microbiology (ASM), Infectious Diseases Society of America (IDSA), The American Society of Health-System Pharmacists, The Society of Infectious Diseases Pharmacists, Animal Welfare Approved (AWA), American Academy of PediatricsAmerican Medical AssociationCompassion in World Farming (CIWF), Center for Science in the Public Interest (CSPI)

Track 10: Drug Discovery and Novel Delivery Technologies

In the prior most drugs have been invented either by identifying the active ingredient from traditional remedies or by serendipitous discovery. A new access has been to recognize how disease and infection are controlled at the molecular and physiological level and to mark specific entities based on this knowledge. The process of drug discovery involves the identification of candidates, characterization, screening, synthesis, and assays for therapeutic efficacy. Evolution of an existing drug molecule from a ordinary form to a novel delivery system can significantly improve its performance in terms of patient compliance, efficacy and safety. These days, drug delivery companies are engaged in the development of numerous platform technologies to get ambitious advantage, extend patent life, and increase market share of their products. Formerly a compound has displayed its value in these tests; it will begin the process of drug development prior to clinical trials.

Relevant Conferences:

2nd International Conference on Infectious Diseases & Diagnostic Microbiology, Sep 11-13, 2022 Dallas, USA; 4th World Congress and Expo on Applied Microbiology, Sep 18-20, 2022 Atlanta, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2022 Atlanta, USA; 2nd International Symposium, Alternatives to Antibiotics, Challenges and Solutions in Animal Production, December 13-15, 2016 Paris, France; Microbiome in Health and Disease, February 5-9, 2022 Colorado, USA; Innovative Strategies in the Research and Development of Antimicrobial Peptides to Increase Therapeutic Potential, February 25-26, 2022 Ventura, CA; How Animals and Plants Use Antimicrobial Peptides, How They Work, and How to Design Interesting New Molecules, February 26 - March 3, 2022 Ventura, CA; 19th International Conference on Antimicrobials, March 9-10, 2022 Miami, USA; BSAC Spring Conference: The Global Challenge of Multi-drug Resistant Gram Negative Bacterial Infections, 14th March 2022, Queen Elizabeth II Conference Centre, London; Solutions for Drug-Resistant Infections Conference, April 3-5, 2022 Brisbane, Australia

Related Societies:

Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), British Pharmacological Society (BPS), American Society for Microbiology (ASM), Infectious Diseases Society of America (IDSA), The American Society of Health-System Pharmacists, The Society of Infectious Diseases Pharmacists, Animal Welfare Approved (AWA), American Academy of PediatricsAmerican Medical AssociationCompassion in World Farming (CIWF), Center for Science in the Public Interest (CSPI), Keep Antibiotics Working (KAW), Institute for Agriculture and Trade Policy (IATP)

Track 11: Antibiotics for Emerging and Re-emerging Diseases

New diseases are originating globally and old diseases are re-emerging as Infectious agents evolve or spread, and as changes occur in conservation, socio-economic conditions, and population patterns. Likewise, many diseases thought to be decently controlled appear to be making a revival. In developed countries, public health measures such as sewage treatment, vaccination programs, sanitation and access to good medical care-including a wide range of antibiotics-have virtually disposed “traditional” diseases such as tuberculosis, diphtheria and whooping cough.

Relevant Conferences:

Annual Conference on Antimicrobials and Drug Resistance, August 24-25, 2022 Toronto, Canada; 2nd International Conference on Infectious Diseases & Diagnostic Microbiology, Sep 11-13, 2022 Dallas, USA; 4th World Congress and Expo on Applied Microbiology, Sep 18-20, 2022 Atlanta, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2022 Atlanta, USA; ASM Microbe 2022, June 1-5, 2022 New Orleans, USA; 2nd International Caparica Conference in Antibiotic Resistance, June 12-15, 2022 Lisbon, Portugal; World Anti-Microbial Resistance Congress USA 2022, September 14-15, 2022 Washington, USA; 11th International Symposium on the Biology of Acinetobacter, September 20-22, 2022 Seville, Spain; Host Directed Therapeutic Strategies to Combat Infection and Reduce Emergence of Drug Resistance Conference, Sep 25- 28 2022, Arizona USA; 19th International Conference on AntibioticsBioactive Compounds and Medicine, October 10-11, 2022 New York, USA

Related Societies:

 Global Antibiotic Resistance Partnership (GARP), British Pharmacological Society (BPS), American Society for Microbiology (ASM), Infectious Diseases Society of America (IDSA), The American Society of Health-System Pharmacists, The Society of Infectious Diseases Pharmacists, Animal Welfare Approved (AWA), American Academy of PediatricsAmerican Medical AssociationCompassion in World Farming (CIWF), Center for Science in the Public Interest (CSPI), Keep Antibiotics Working (KAW), Institute for Agriculture and Trade Policy (IATP), Healthy Food Action

Track 12: Micro Organisms in Recent Drug Discovery

Environmental microbes are a leading source of drug discovery, and several microbial products ( anti-tumour products, antibiotics, immunosuppressants and others) are used frequently for human therapies. Most of these products were accessed from cultivable (<1%) environmental microbes, means that the large number of microbes were not targeted for drug discovery. With the onset of new and emerging technologies, we are poised to harvest novel drugs from the so-called 'uncultivable' microbes. Multidisciplinary way of linking different technologies can assist and reform drug discovery from uncultivable microbes and inspect the current cramp of technologies and scenario to swamped such constraints that might further expand the promise of drugs from environmental microbes.

Relevant Conferences:

2nd International Conference on Infectious Diseases & Diagnostic Microbiology, Sep 11-13, 2022 Dallas, USA; 4th World Congress and Expo on Applied Microbiology, Sep 18-20, 2022 Atlanta, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2022 Atlanta, USA; 2nd International Symposium, Alternatives to Antibiotics, Challenges and Solutions in Animal Production, December 13-15, 2016 Paris, France; Microbiome in Health and Disease, February 5-9, 2022 Colorado, USA; Innovative Strategies in the Research and Development of Antimicrobial Peptides to Increase Therapeutic Potential, February 25-26, 2022 Ventura, CA; How Animals and Plants Use Antimicrobial Peptides, How They Work, and How to Design Interesting New Molecules, February 26 - March 3, 2022 Ventura, CA; 19th International Conference on Antimicrobials, March 9-10, 2022 Miami, USA; BSAC Spring Conference: The Global Challenge of Multi-drug Resistant Gram Negative Bacterial Infections, 14th March 2022, Queen Elizabeth II Conference Centre, London; Solutions for Drug-Resistant Infections Conference, April 3-5, 2022 Brisbane, Australia

Related Societies:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), Center for a Livable Future (CLF), U.S. Food and Drug Administration (FDA), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsTransatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), British Pharmacological Society (BPS)

Track 13: Clinical Trials of Antibiotics

Prescribing doctors are, progressively, using clinical trial data as a major source of information for evidence-based medicine for the remedy of infectious diseases, as in other clinical disciplines. However, it may be difficult to excerpt from these data the material that is needed for the management of the individual patient. At the same time, clinical trial testimony have been used, probably satisfactorily, in the process of drug registration, and the pharmaceutical industry has spent progressively large amount of money to satisfy the needs of this process. In the face of all these problems, switch in the way antibiotic clinical trials are designed and performed are clearly necessary, although this must not disturb the balance so far as to restore them less useful for those who currently derive greatest benefit from them.

Relevant Conferences:

2nd International Conference on Infectious Diseases & Diagnostic Microbiology, Sep 11-13, 2022 Dallas, USA; 4th World Congress and Expo on Applied Microbiology, Sep 18-20, 2022 Atlanta, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2022 Atlanta, USA; 2nd International Symposium, Alternatives to Antibiotics, Challenges and Solutions in Animal Production, December 13-15, 2016 Paris, France; Microbiome in Health and Disease, February 5-9, 2022 Colorado, USA; Innovative Strategies in the Research and Development of Antimicrobial Peptides to Increase Therapeutic Potential, February 25-26, 2022 Ventura, CA; How Animals and Plants Use Antimicrobial Peptides, How They Work, and How to Design Interesting New Molecules, February 26 - March 3, 2022 Ventura, CA; 19th International Conference on Antimicrobials, March 9-10, 2022 Miami, USA; BSAC Spring Conference: The Global Challenge of Multi-drug Resistant Gram Negative Bacterial Infections, 14th March 2022, Queen Elizabeth II Conference Centre, London; Solutions for Drug-Resistant Infections Conference, April 3-5, 2022 Brisbane, Australia

Related Societies:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), Center for a Livable Future (CLF), U.S. Food and Drug Administration (FDA), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsTransatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), British Pharmacological Society (BPS), American Society for Microbiology (ASM), Infectious Diseases Society of America (IDSA), The American Society of Health-System Pharmacists, The Society of Infectious Diseases Pharmacists, Animal Welfare Approved (AWA), American Academy of Pediatrics

Track 14: Antibiotics and Mechanism of Action

Antibacterial action customarily falls within one of four mechanisms, three of which involve the inhibition or regulation of enzymes tangled in cell wall biosynthesis, nucleic acid metabolism and repair, or protein synthesis, respectively. The fourth mechanism associates the interruption of membrane structure. Many of these cellular functions targeted by antibiotics are most effective in multiplying cells. Since there is often overlap in these functions between eukaryotic mammalian cells and prokaryotic bacterial cells, it is not surprising that some antibiotics have also been found to be useful as anticancer agents.

Relevant Conferences:

Annual Conference on Antimicrobials and Drug Resistance, August 24-25, 2022 Toronto, Canada; 2nd International Conference on Infectious Diseases & Diagnostic Microbiology, Sep 11-13, 2022 Dallas, USA; 4th World Congress and Expo on Applied Microbiology, Sep 18-20, 2022 Atlanta, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2022 Atlanta, USA; ASM Microbe 2022, June 1-5, 2022 New Orleans, USA; 2nd International Caparica Conference in Antibiotic Resistance, June 12-15, 2022 Lisbon, Portugal; World Anti-Microbial Resistance Congress USA 2022, September 14-15, 2022 Washington, USA; 11th International Symposium on the Biology of Acinetobacter, September 20-22, 2022 Seville, Spain; Host Directed Therapeutic Strategies to Combat Infection and Reduce Emergence of Drug Resistance Conference, Sep 25- 28 2022, Arizona USA; 19th International Conference on AntibioticsBioactive Compounds and Medicine, October 10-11, 2022 New York, USA

Related Societies:

 Centers for Disease Control and Prevention (CDC), Center for a Livable Future (CLF), U.S. Food and Drug Administration (FDA), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsTransatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), British Pharmacological Society (BPS), American Society for Microbiology (ASM), Infectious Diseases Society of America (IDSA), The American Society of Health-System Pharmacists, The Society of Infectious Diseases Pharmacists, Animal Welfare Approved (AWA), American Academy of PediatricsAmerican Medical AssociationCompassion in World Farming (CIWF), Center for Science in the Public Interest (CSPI)

Track 15: Antibiotic Regulatory Affairs

 Regulatory affairs (RA), are also called as government affairs, is a profession within regulated industries, such as medical devices, pharmaceuticals etc. Regulatory affairs also have a very specific meaning within the healthcare industries (medical devices, functional foods, biologics and pharmaceuticals). Regulatory affairs (medical affairs) professionals (aka regulatory professionals) generally have the duty for the following general areas: Ensuring that the companies obey with all of the regulations and laws pertaining to their business.

Relevant Conferences:

Global Pharmaceutical Microbiology Conference, June 19-20, 2022 London, UK; Annual Conference on Antimicrobials and Drug Resistance, August 24-25, 2022 Toronto, Canada; 2nd International Conference on Infectious Diseases & Diagnostic Microbiology, Sep 11-13, 2022 Dallas, USA; 4th World Congress and Expo on Applied Microbiology, Sep 18-20, 2022 Atlanta, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2022 Atlanta, USA; BSAC Spring Conference: The Global Challenge of Multi-drug Resistant Gram Negative Bacterial Infections, 14th March 2022, Queen Elizabeth II Conference Centre, London; Solutions for Drug-Resistant Infections Conference, April 3-5, 2022 Brisbane, Australia; ASM Conference on Innovative Microbial Ecology for Mitigation of Antibiotic Resistance and Bacterial Diseases, March 22–25, 2022 Crystal City, VA; 27th European Congress of Clinical Microbiology and Infectious Diseases, April 22- 25 2022 Vienna, Austria; 20th Annual MAD-ID Meeting – THE Antimicrobial Stewardship Meeting™, May 10-13, 2022 Orlando, USA; ASM Microbe 2022, June 1-5, 2022 New Orleans, USA; 2nd International Caparica Conference in Antibiotic Resistance, June 12-15, 2022 Lisbon, Portugal; World Anti-Microbial Resistance Congress USA 2022, September 14-15, 2022 Washington, USA; 11th International Symposium on the Biology of Acinetobacter, September 20-22, 2022 Seville, Spain; Host Directed Therapeutic Strategies to Combat Infection and Reduce Emergence of Drug Resistance Conference, Sep 25- 28 2022, Arizona USA; 19th International Conference on Antibiotics, Bioactive Compounds and Medicine, October 10-11, 2022 New York, USA

Related Societies:

U.S. Food and Drug Administration (FDA), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsTransatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), British Pharmacological Society (BPS), American Society for Microbiology (ASM), Infectious Diseases Society of America (IDSA), The American Society of Health-System Pharmacists, The Society of Infectious Diseases Pharmacists, Animal Welfare Approved (AWA), American Academy of PediatricsAmerican Medical AssociationCompassion in World Farming (CIWF), Center for Science in the Public Interest (CSPI), Keep Antibiotics Working (KAW), Institute for Agriculture and Trade Policy (IATP), Healthy Food Action

Track 16: Antibiotics: Market Analysis and Business Opportunities

The global antibiotics market was valued at $39.6 billion in 2013 and is expected to reach $41.2 billion by 2018, at a CAGR of 0.8%. From, 2005 this market is seen to grow at an annual rate of 6.6% until 2011. There are many companies producing antibiotics these days and there are many other antibiotics present in the market such as aminoglycoside antibiotics and it cap around 79% of the global demand. Moreover, the other antibiotics such as penicillin have 8%, streptomycin 1%, chloramnphenicol 1 %, tetracyclines 4%, erythromycin has 7%, market.

Relevant Conferences:

7th World Congress on Clinical Microbiology, February 27-28, 2022 Amsterdam, Netherlands; Global Pharmaceutical Microbiology Conference, June 19-20, 2022 London, UK; Annual Conference on Antimicrobials and Drug Resistance, August 24-25, 2022 Toronto, Canada; 2nd International Conference on Infectious Diseases & Diagnostic Microbiology, Sep 11-13, 2022 Dallas, USA; 4th World Congress and Expo on Applied Microbiology, Sep 18-20, 2022 Atlanta, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2022 Atlanta, USA; 2nd International Symposium, Alternatives to Antibiotics, Challenges and Solutions in Animal Production, December 13-15, 2016 Paris, France; Microbiome in Health and Disease, February 5-9, 2022 Colorado, USA; Innovative Strategies in the Research and Development of Antimicrobial Peptides to Increase Therapeutic Potential, February 25-26, 2022 Ventura, CA; How Animals and Plants Use Antimicrobial Peptides, How They Work, and How to Design Interesting New Molecules, February 26 - March 3, 2022 Ventura, CA; 19th International Conference on Antimicrobials, March 9-10, 2022 Miami, USA; BSAC Spring Conference: The Global Challenge of Multi-drug Resistant Gram Negative Bacterial Infections, 14th March 2022, Queen Elizabeth II Conference Centre, London; Solutions for Drug-Resistant Infections Conference, April 3-5, 2022 Brisbane, Australia; ASM Conference on Innovative Microbial Ecology for Mitigation of Antibiotic Resistance and Bacterial Diseases, March 22–25, 2022 Crystal City, VA; 27th European Congress of Clinical Microbiology and Infectious Diseases, April 22- 25 2022 Vienna, Austria; 20th Annual MAD-ID Meeting – THE Antimicrobial Stewardship Meeting™, May 10-13, 2022 Orlando, USA;

Related Societies:

ReAct – Action on AntibioticsTransatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), British Pharmacological Society (BPS), American Society for Microbiology (ASM), Infectious Diseases Society of America (IDSA), The American Society of Health-System Pharmacists, The Society of Infectious Diseases Pharmacists, Animal Welfare Approved (AWA), American Academy of PediatricsAmerican Medical AssociationCompassion in World Farming (CIWF), Center for Science in the Public Interest (CSPI)

About Conference


After a successful conference of Antibiotics 2021, we are currently bringing forth “9th World Congress and Exhibition on Antibiotics and Antibiotic Resistance” (Antibiotics 2021) slated on March 07-08, 2022 Barcelona, Spain. Antibiotics 2022 welcomes attendees, participants, students, speakers, organizing committee members, delegates from all over the world. We welcome you and appreciate your participation at the Barcelona, Spain and it will be organized around the theme "Current Research: Tackling Antibiotic Resistance and COVID-19" which includes prompt Keynote presentationsOral talksPoster presentations and Exhibitions.

Antibiotics 2022 will be organizing webinars by offering virtual platform to all academicians, researchers, industry professional, and scholars. will be scheduled on wide range of topics and it will be helpful for scientific fraternity to be connected while staying at their preferred place. Join the webinars organized by us and let the world know about your research and innovation. The Antibiotics 2022 conference hosting presentations from editors of eminent refereed journals, renowned and active investigators and decision makers in the field of Pharmacology, Infectious Diseases, Microbiology, Immunology, Bacteriology and many more. Antibiotics 2022 Organizing Committee also invites young investigators at each and every career stage to submit abstracts reporting their latest scientific research in oral and poster sessions.

We organize a series of 3000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Antibiotics 2022 is intended to honour prestigious award for talented Young researchers, Scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, junior faculty in recognition of their outstanding contribution towards the conference theme. The Young Scientist Awards make every effort in providing a strong professional development opportunity for early career academicians by meeting experts to exchange and share their experiences on all aspects of Pharmacology.

Young Research’s Awards at Antibiotics 2022 for the Nomination:

Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation and only 25 presentations acceptable at the Antibiotics 2022.

YRF Registration benefits:

  • Our conferences provide best Platform for your research through oral presentations.
  • Share the ideas with both eminent researchers and mentors.
  • Young Scientist Award reorganization certificate and memento to the winners
  • Young Scientists will get appropriate and timely information by this Forum.
  • Platform for collaboration among young researchers for better development
  • Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.

Why to attend?

Antibiotics 2022 is a platform to discuss and learn about the latest advancements in the field of Antibiotics and Antibiotic Resistance as the world’s consideration turned regarding the urgency of new antibiotics as the antimicrobial resistance is growing day by day. Many developed nations and International health organizations are trying to focus of the current situation and making new policies to prevent the adverse effects of Antibiotic resistance.

The 2-day conference gathers Researchers, academia, labs, Drug Manufacturers, government agencies, health professionals, hospitals, young investigators, Pharma and labs and presents their opinions through key notes, and case study presentations. This conference lays a platform for all the researchers working in the field of Antibiotics to know the latest developments and the current situation of the Antibiotic resistance problem.

Market Analysis

Antibiotics 2022 Market Analysis

The global antibiotics market was valued at USD 42,653.89 million in 2018, and is estimated to be valued at USD 56,369.92 million in 2024, witnessing a CAGR of 4.7%.The Antibacterial Drugs market is expected to cross US$ 38 Billion by 2024 growing at a CAGR of 1% during the given forecast period. Rising pervasiveness of irresistible illnesses particularly in creating locales, for example, Asia Pacific and MEA is foreseen to contribute towards showcase development.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players include Allergen plc, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly & Co., Forest Laboratories, Inc., GlaxoSmithKline plc, Merck & Co., Inc. Novartis AG, Pfizer, Inc., and Sanofi.

The antibiotics market generated sales of US$42 billion in 2009 globally, representing 46% of sales of anti-infective agents (which also include antiviral drugs and vaccines) and 5% of the global pharmaceutical market. However, the antibiotics market is maturing; it showed an average annual growth of 4% over the past 5 years, compared with a growth of 16.7% and of 16.4% for antiviral drugs and vaccines, respectively.

Over 15.0% of the passing’s, in kids underneath the age of five, are assessed to be because of pneumonia and as indicated by the insights given by the WHO around 9.2 million passing’s were recorded in 2015. Like tuberculosis, the most elevated commonness of the sickness is recognized to be in the South Asian and Sub-Saharan locales. At present, the required anti-infection treatment is accessible just to 33% of the tainted populace, subsequently expanding the illness trouble.

The major driving factors of Antibacterial Drugs Market are as follows:

  • There is a very high prevalence of infectious diseases.
  • The research and development activities have increased.
  • Product differentiation through various methods.
  • Increased government support.

The restraining factors of Antibacterial drugs Market is as follows:

Importance and Scope

Antibiotic resistance is rising to dangerously high levels in all parts of the world. New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases. A growing list of infections such as pneumonia, tuberculosis, blood poisoning, gonorrhoea, and foodborne diseases are becoming harder, and sometimes impossible, to treat as antibiotics become less effective.

Where antibiotics can be bought for human or animal use without a prescription, the emergence and spread of resistance is made worse. Similarly, in countries without standard treatment guidelines, antibiotics are often over-prescribed by health workers and veterinarians and over-used by the public. Without urgent action, we are heading for a post-antibiotic era, in which common infections and minor injuries can once again kill.

Target Audience

Related Companies

  1. Gilead Sciences
  2. Pfizer
  3. Abbott Laboratories
  4. Merck & Co
  5. Eli Lilly
  6. Astellas Pharma
  7. Teva Pharmaceutical Industries
  8. Boehringer Ingelheim
  9. Roche
  10. Mylan
  11. 3-D Matrix
  12. Agilent
  13. BeiGene
  14. BioDuro
  15. Fosun Pharma

Related Associations and Societies 

  1. World Health Organization
  2. U.S. Food and Drug Administration (FDA)
  3. Natural Resources Defense Council (NRDC)
  4. Infectious Diseases Society of America
  5. World Health Assembly
  6. Center for a Livable Future (CLF)
  7. The Humane Society of the United States (HSUS)
  8. Alliance for the Prudent Use of Antibiotics
  9. Civil Society Organisations
  10. British Society for Antimicrobial Chemotherapy

 

 

Past Conference Report

Antibiotics 2021

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date March 07-08, 2022

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Journal of Drug Metabolism & Toxicology Advances in Antibiotics & Antibodies Drug Designing: Open Access

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Keytopics

  • Aminoglycosides
  • Ansamycins
  • Anti-bacterials
  • Anti-migraine Agents
  • Antibacterial Resistance
  • Antibacterial Stewardship
  • Antibacterials
  • Antibiotic Discovery
  • Antibiotic Prophylaxis
  • Antibiotic Resistance
  • Antibiotic Resistance Bacteria
  • Antibiotic Resistance Evolution
  • Antibiotic Selection
  • Antibiotic Stewardship
  • Antibiotic Susceptibility
  • Antibiotic Therapy
  • Antibiotics
  • Antibiotics And Alternatives
  • Antibiotics For Emerging
  • Antibiotics In Aquaculture
  • Antibiotics In Food Industry
  • Antibiotics In Veterinary
  • Antibiotics Research
  • Anticancer Antibiotics
  • Antifungals
  • Antimicrobial Agents
  • Antimicrobial Peptides
  • Antimicrobial Resistance
  • Antimicrobial Resistance
  • Antimicrobial Stewardship
  • Antimicrobial Stewardship
  • Antimicrobials
  • Bacterial Antibiotic Resistance
  • Bacterial Biofilms
  • Bacterial Diseases
  • Bacterial Infection
  • Bacterial Infectious Diseases
  • Bactericidal Action
  • Bacteriology
  • Bacteriostatic
  • Broad Spectrum
  • Carbapenems
  • Cephalosporins
  • Ciprofloxacin
  • Clinical Infectious Diseases
  • Computational Biology
  • Drug Resistance
  • Drug-resistant Infection
  • Emergence Of Antimicrobial Resistance
  • Emerging Infectious Diseases
  • Escherichia Coli
  • Fluoroquinolones
  • Glycopeptides
  • Hypocholesterolemic Agents
  • Immunology Of Infections
  • Immunomodulation
  • Immunosuppressive Agents
  • Infection
  • Infections Prevention
  • Infectious Diseases
  • Inhaled Antibiotics
  • Lactam-resistant Bacteria
  • Ligand Binding Studies
  • Lincosamides
  • Lipopeptide
  • Macrolides
  • Mechanism Of Resistance
  • Medication Procedures
  • Methicillin-Resistant Staphylococcus Aureus (MRSA)
  • Microbes
  • Microbiology
  • Monobactams
  • Multiresistant Bacteria
  • Narrow Spectrum
  • Nitrofurans
  • Novel Antibacterial Drug Discovery
  • Novel Antibiotics
  • Nuclear Material
  • Oral Antibiotic Therapy
  • Oral Antibiotics
  • Oxazolidinones
  • Pathogenic Bacteria
  • Penicillin
  • Penicillins
  • Pharmacodynamics Of Antibiotics
  • Pharmacokinetics Of Antibiotics
  • Polypeptides
  • Prophylactic Antibiotics
  • Protein
  • Public Health
  • Quinolones
  • Resistance And Re-emerging Theories
  • Resistant Infections
  • Streptomycin
  • Sulfonamides
  • Tetracycline
  • Tetracyclines
  • Tropical Infectious Diseases
  • Vancomycin Resistant Enterococci (VRE)